Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Cancer

Last data update: Sep 24, 2022. (Total: 49607 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 4602 Records)

Next

Query Trace: all[original query]>>Reviews/Commentaries[Product Type]
Role of genetic testing in hepatic, pancreatic, and biliary cancers.
Hewitt D Brock et al. Surgical oncology 2022 44101844
Considerations of biomarker application for cancer continuum in the era of precision medicine.
Hung Rayjean J et al. Current epidemiology reports 2022 9(3) 200-211
The Progress of the Specific and Rapid Genetic Detection Methods for Ovarian Cancer Diagnosis and Treatment.
Dong Kejun et al. Technology in cancer research & treatment 2022 2115330338221114497
BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors.
Talloa Dario et al. Cancers 2022 14(17)
Using Genetic Testing at Cancer Diagnosis for Breast Cancer Control.
Sun Li et al. China CDC weekly 2022 4(32) 711-714
Hereditary Cancer Syndromes-A Broader Clinical Spectrum Than Previously Understood?
Puthanmadhom Narayanan Susrutha et al. JAMA oncology 2022
Moving Prostate Cancer Polygenic Risk Scores from Research Towards Clinical Practice.
Kearns James T et al. European urology focus 2022
The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice.
Mohindroo Chirayu et al. Surgical pathology clinics 2022 15(3) 491-502
Familial colorectal cancer.
Mangas-Sanjuan Carolina et al. Best practice & research. Clinical gastroenterology 2022 58-59101798
BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside.
Boussios Stergios et al. Cancers 2022 14(16)
Presentation, diagnosis, and management of the Li-Fraumeni syndrome.
Ogden John et al. Proceedings (Baylor University. Medical Center) 2022 35(5) 678-679
How I Use It: The Exosome Diagnostics (EPI) prostate cancer biomarker utility in urology and primary care.
Moul Judd W et al. The Canadian journal of urology 2022 29(4) 11224-11230
Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: Which role for gene expression assays?
Garufi Giovanna et al. Cancer treatment reviews 2022 110102454
Carrier screening: an update.
Zhang Kuo et al. Clinica chimica acta; international journal of clinical chemistry 2022
Routine informed consent for mismatch repair testing in endometrial cancers: Review and ethical analysis.
DeMari Joseph A et al. Gynecologic oncology 2022
Li-Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment.
Rocca Valentina et al. Cancers 2022 14(15)
Next-generation sequencing, should I use anti-HER2 therapy for HER2-amplified tumors off-label? Illustrating an extrapolation framework.
Cho Doah et al. Therapeutic advances in medical oncology 2022 1417588359221112822
Bridging the implementation gap: delivering complex genomic analysis for routine cancer care.
Beer Philip A et al. Annals of oncology : official journal of the European Society for Medical Oncology 2022
Clinical Utility of Genomic Assay in Node-Positive Early-Stage Breast Cancer.
Pauls Mehrnoosh et al. Current oncology (Toronto, Ont.) 2022 29(7) 5139-5149
Ovarian tumors and genetic predisposition.
Štellmachová Júlia et al. Ceska gynekologie 2022 87(3) 211-216
Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention.
Tindale Lauren C et al. Current oncology (Toronto, Ont.) 2022 29(7) 4632-4646
Polygenic risk score in prostate cancer.
Oh Jong Jin et al. Current opinion in urology 2022
Expert opinion on NSCLC small specimen biomarker testing - Part 2: Analysis, reporting, and quality assessment.
Penault-Llorca Frédérique et al. Virchows Archiv : an international journal of pathology 2022
Prognostic Role of RNA Expression Molecular Biomarkers in Prostate and Bladder Cancers.
Ahmed Mohamed E et al. European urology focus 2022
Inherited genetics of adult diffuse glioma and polygenic risk scores-a review.
Eckel-Passow Jeanette E et al. Neuro-oncology practice 2022 9(4) 259-270
Developing a Classification of Hematologic Neoplasms in the Era of Precision Medicine.
Cazzola Mario et al. Blood 2022
Challenges and Obstacles in Applying Therapeutical Indications Formulated in Molecular Tumor Boards.
Crimini Edoardo et al. Cancers 2022 14(13)
Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care.
Casolino Raffaella et al. Cancers 2022 14(13)
Pan-cancer analysis reveals distinct clinical, genomic, and immunological features of the LILRB immune checkpoint family in acute myeloid leukemia.
Xu Zi-Jun et al. Molecular therapy oncolytics 2022 2688-104
Variation and Disparity in the Use of Prostate Cancer Risk Stratification Tools in the United States.
Laditi Folawiyo et al. European urology focus 2022
TOP